Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Area of Science:

• Biochemistry
• Immunology
• Metabolomics

Background:

• Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, debilitating illness with diverse symptoms including fatigue, cognitive issues, and sleep disturbances.
• Many ME/CFS patients report an infection-like prodrome, suggesting infectious triggers or immune system involvement.
• Current understanding of ME/CFS pathogenesis remains incomplete, necessitating further investigation into underlying biological mechanisms.

Purpose of the Study:

• To investigate plasma metabolomic profiles in ME/CFS patients compared to healthy controls.
• To identify specific metabolic alterations associated with ME/CFS.
• To explore the potential of metabolomic data for ME/CFS diagnosis and understanding disease mechanisms.

Main Methods:

• Targeted and untargeted metabolomic analysis of plasma samples from 106 ME/CFS cases and 91 healthy controls.
• Statistical analyses including regression, Bayesian, and enrichment analyses were employed.
• Machine learning algorithms were used to assess the diagnostic potential of identified metabolic signatures.

Main Results:

• ME/CFS patients exhibited significantly decreased levels of plasmalogens, phospholipid ethers, phosphatidylcholines, and sphingomyelins.
• Elevated levels of dicarboxylic acids were observed in the ME/CFS group.
• Machine learning models achieved an area under the receiver operating characteristic curve (AUC) up to 0.873 in differentiating ME/CFS from controls.

Conclusions:

• The study provides the first metabolomic evidence suggesting peroxisomal dysfunction in ME/CFS.
• Findings indicate dysregulation in lipid remodeling and the tricarboxylic acid cycle in ME/CFS.
• Plasma metabolomic profiling may offer valuable biomarkers for ME/CFS diagnosis and understanding its pathogenesis, pending validation in larger cohorts.